Retrospective Analysis of Potential Adverse Drug Interactions in the Drugs Prescribed to the Elderly at a Tertiary Health Care Center in Raipur, Chhattisgarh, Central India.
| Autor: | Rajendran Y; Pharmacology, All India Institute of Medical Sciences, Raipur, Raipur, IND., Keche Y; Pharmacology, All India Institute of Medical Sciences, Raipur, Raipur, IND., Gaikwad NR; Pharmacology, All India Institute of Medical Sciences, Raipur, Raipur, IND., Dhaneria S; Pharmacology and Therapeutics, Ruxmaniben Deepchand Gardi Medical College, Ujjain, IND. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 Feb 07; Vol. 16 (2), pp. e53767. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.53767 |
| Abstrakt: | Background The elderly population differs from adults in having various physiological changes and multiple diseases, which demand the use of multiple medications. The practice of polypharmacy in the elderly leads to numerous harmful effects like adverse drug reactions, adverse drug-drug interactions (DDIs), poor compliance, etc. Methodology This study collected 295 case files of elderly patients retrospectively in the Departments of General Medicine, Cardiology and Nephrology after obtaining Institute Ethics Committee approval to look for the potential adverse DDIs with their severity according to the clinical significance. Results and interpretation The total number of adverse DDIs identified was 156, the maximum in Category 'C.' Salbutamol plus carvedilol/propranolol, ramipril plus telmisartan and ivabradine plus diltiazem were the adverse DDIs categorized under severity 'X'. The identified DDIs were categorised according to the mechanism such as increased bleeding risk, hypokalemia, hyperkalaemia, reduced effect of drugs and increased effect of drugs. Conclusion Polypharmacy can lead to several adverse consequences in the elderly, of which adverse DDIs play a crucial role in harmful health outcomes. This study brings out the significance of predicting drug interactions beforehand which can reduce the risk of bleeding and other risks of hyper/hypokalaemia, hyponatremia and hypoglycaemia. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Rajendran et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|